MAP2K7 and malignant colon neoplasm: Multiple studies using in vivo colon cancer models showed that MEK inhibition potentiates the anti‐tumor immune response by preventing T cell apoptosis and decreasing levels of myeloid suppressor cells and regulatory T cells.